Literature DB >> 19914289

Induction of T cells suppression by dendritic cells transfected with VSIG4 recombinant adenovirus.

Shuxiong Xu1, Zhaolin Sun, Lian Li, Jun Liu, Jian He, Dalong Song, Gang Shan, Hong Liu, Xiongfei Wu.   

Abstract

VSIG4 has been recently described as a B7 family-related protein. The immunotherapeutic potential of dendritic cells (DCs) transfected with VSIG4 recombinant adenovirus has not been characterized. In the present study, DCs were transfected with human VSIG4 (hVSIG4) recombinant adenovirus, a novel costimulatory molecule known to be a potent inhibitor of T cell activation. Transfected DCs were cocultured with allogeneic T cells and proliferation, cytokine production and T cell activation marker expression were assessed. The results showed that T cell proliferation potential, cytokine production and activation marker expression were suppressed after coculture with hVSIG4 recombinant adenovirus-transfected DCs. These findings suggest that DCs transfected with hVSIG4 recombinant adenovirus are capable of inducing allogeneic T cell suppression, which represents an ideal strategy for manipulating the immune response to transplanation or autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914289     DOI: 10.1016/j.imlet.2009.11.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Regulation of CRIg expression and phagocytosis in human macrophages by arachidonate, dexamethasone, and cytokines.

Authors:  Nick N Gorgani; Umaporn Thathaisong; Violet R S Mukaro; Ornnuthchar Poungpair; Amanda Tirimacco; Charles S T Hii; Antonio Ferrante
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

2.  Proinvasion metastasis drivers in early-stage melanoma are oncogenes.

Authors:  Kenneth L Scott; Cristina Nogueira; Timothy P Heffernan; Remco van Doorn; Sabin Dhakal; Jason A Hanna; Chengyin Min; Mariela Jaskelioff; Yonghong Xiao; Chang-Jiun Wu; Lisa A Cameron; Samuel R Perry; Rhamy Zeid; Tamar Feinberg; Minjung Kim; George Vande Woude; Scott R Granter; Marcus Bosenberg; Gerald C Chu; Ronald A DePinho; David L Rimm; Lynda Chin
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

3.  Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging.

Authors:  Wenxian Fu; Gregory Wojtkiewicz; Ralph Weissleder; Christophe Benoist; Diane Mathis
Journal:  Nat Immunol       Date:  2012-02-26       Impact factor: 25.606

4.  Human Dendritic Cells Express the Complement Receptor Immunoglobulin Which Regulates T Cell Responses.

Authors:  Usma Munawara; Khalida Perveen; Annabelle G Small; Trishni Putty; Alex Quach; Nick N Gorgani; Charles S Hii; Catherine A Abbott; Antonio Ferrante
Journal:  Front Immunol       Date:  2019-12-10       Impact factor: 7.561

5.  Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma.

Authors:  Wei-Feng Zong; Cui Liu; Yi Zhang; Suo-Jun Zhang; Wen-Sheng Qu; Xiang Luo
Journal:  J Oncol       Date:  2022-08-29       Impact factor: 4.501

Review 6.  V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy.

Authors:  Xia Zhou; Sohail Khan; Dabing Huang; Lu Li
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.